This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kilic, E. Articles by Hermann, D. M. Search for Related Content PubMed PubMed Citation Articles by Kilic, E. Articles by Hermann, D. M. Related Collections Heparin Thrombolysis

(Stroke. 2001;32:2641.)
© 2001 American Heart Association, Inc.

Original Contributions

Effects of Recombinant Tissue Plasminogen Activator After Intraluminal Thread Occlusion in Mice

Role of Hemodynamic Alterations

Ertugrul Kilic, PhD; Mathias Bähr, MD Dirk M. Hermann, MD

From the Department of Neurology, Eberhard-Karls University, Tübingen, Germany.

Correspondence to Ertugrul Kilic, PhD, Department of Neurology, Georg August University, Robert-Koch-Str 40, D-37075 Göttingen, Germany. E-mail kilic44{at}yahoo.com

Background and Purpose—— It has been suggested that recombinant tissue plasminogen activator (rtPA) may cause an aggravation of injury after transient focal ischemia via excitotoxic side effects. Such rtPA toxicity would be of major clinical significance since rtPA is increasingly used in stroke treatment. This study was conducted to evaluate the effects of dose, application time, and hemodynamic changes after intravenous rtPA treatment in focal ischemia.

Methods—— Mice were subjected to a 90-minute episode of middle cerebral artery thread occlusion, and rtPA effects were assessed by laser-Doppler flowmetry, [¹⁴C]iodoantipyrine autoradiography, and triphenyltetrazolium chloride staining.

Results and Conclusions—— We provide evidence that rtPA provokes complex hemodynamic alterations in the ischemic brain tissue, which include an initial hyperperfusion and a more delayed hypoperfusion response. Changes are most pronounced in the periphery of the ischemic infarct, where regional blood flow drops below critical thresholds of tissue viability. Our observations suggest that changes of perfusion may at least partly explain the rtPA-induced increase of infarct size, which has previously been reported and which we also confirmed in the present experiments. Notably, both the secondary hypoperfusion and increase of infarct volume were abolished when rtPA-treated animals received additional heparin infusions. This finding suggests that a secondary hypercoagulability may compromise brain perfusion after rtPA delivery. Accordingly, early treatment with heparin might help to prevent the rtPA-induced changes.

Key Words: hemodynamics • heparin • ischemia, focal • plasminogen activator, tissue-type • thrombolysis • mice

This article has been cited by other articles:

				S. Jang, J.-C. Jung, D. H. Kim, J. H. Ryu, Y. Lee, M. Jung, and S. Oh The Neuroprotective Effects of Benzylideneacetophenone Derivatives on Excitotoxicity and Inflammation via Phosphorylated Janus Tyrosine Kinase 2/Phosphorylated Signal Transducer and Activator of Transcription 3 and Mitogen-Activated Protein K Pathways J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 435 - 447. [Abstract] [Full Text] [PDF]

				N. Wilczak, J. W. Elting, D. Chesik, I. P. Kema, and J. De Keyser Intravenous Tissue Plasminogen Activator in Patients With Stroke Increases the Bioavailability of Insulin-Like Growth Factor-1 Stroke, September 1, 2006; 37(9): 2368 - 2371. [Abstract] [Full Text] [PDF]

				K. Benchenane, V. Berezowski, C. Ali, M. Fernandez-Monreal, J. P. Lopez-Atalaya, J. Brillault, J. Chuquet, A. Nouvelot, E. T. MacKenzie, G. Bu, et al. Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor-Related Protein-Mediated Transcytosis Circulation, May 3, 2005; 111(17): 2241 - 2249. [Abstract] [Full Text] [PDF]

				E. Kilic, U. Kilic, C. M. Matter, T. F. Luscher, C. L. Bassetti, and D. M. Hermann Aggravation of Focal Cerebral Ischemia by Tissue Plasminogen Activator Is Reversed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor but Does Not Depend on Endothelial NO Synthase Stroke, February 1, 2005; 36(2): 332 - 336. [Abstract] [Full Text] [PDF]

				Y. Wang, E. Kilic, U. Kilic, B. Weber, C. L. Bassetti, H. H. Marti, and D. M. Hermann VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena Brain, January 1, 2005; 128(1): 52 - 63. [Abstract] [Full Text] [PDF]

				S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function Stroke, December 1, 2003; 34(12): 2975 - 2979. [Abstract] [Full Text] [PDF]

				U. Kilic, E. Kilic, G. P.H. Dietz, and M. Bahr Intravenous TAT-GDNF Is Protective After Focal Cerebral Ischemia in Mice Stroke, May 1, 2003; 34(5): 1304 - 1310. [Abstract] [Full Text] [PDF]